Rchr
J-GLOBAL ID：201801017860598459
Update date: Apr. 24, 2024
NAGAI HIROKAZU
ナガイ ヒロカズ | NAGAI HIROKAZU
Affiliation and department：
Research field (1)：
Hematology and oncology
Research keywords (3)：
climical oncoloty
, malignant lympoma
, hematology
Research theme for competitive and other funds (4)：
- 2011 - 2012 Comparative effectiveness research in first-line therapies for untreated multiple myeloma
- 2010 - 2012 p57KIP2 methylation as a prognostic biomarker of malignant lymphoma
- 2007 - 2008 The analysis of p57KIP2 gene in hematologic malignancies
- 2004 - 2005 Analysis of p57KIP2 gene as tumor suppressor gene
Papers (142)：
-
Takashi Watanabe, Yoshihiro Matsuno, Masashi Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, et al. Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203. Hematological oncology. 2024. 42. 3. e3272
-
Takashi Watanabe, Kensei Tobinai, Masaki Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, et al. R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203. British Journal of Haematology. 2023
-
Michinori Ogura, Kazuhito Yamamoto, Yasuo Morishima, Masashi Wakabayashi, Kensei Tobinai, Kiyoshi Ando, Naokuni Uike, Mitsutoshi Kurosawa, Hiroshi Gomyo, Masafumi Taniwaki, et al. Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406. Cancer science. 2023. 114. 8. 3461-3465
-
Tomoki Naoe, Akiko Saito, Nahoko Hosono, Senji Kasahara, Hideharu Muto, Kaoru Hatano, Mizuki Ogura, Taro Masunari, Masatsugu Tanaka, Kensuke Usuki, et al. Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide. Cancer immunology, immunotherapy : CII. 2023. 1-7
-
Tomonori Kawasaki, Tomoaki Tashima, Atsushi Enomoto, Tetsuo Kondo, Hirokazu Nagai, Yasuhiro Nakamura, Jiro Ichikawa, Kiyomi Taniyama, Kyoichi Kaira. Neuroendocrine neoplasms of the breast: diagnostic confusion and future perspectives. Virchows Archiv : an international journal of pathology. 2023. 482. 5. 929-930
ｍore...
MISC (41)：
-
Shinichi Makita, Shigeru Kusumoto, Jun-Ichi Tamaru, Hiroya Hashimoto, Akiko Miyagi Maeshima, Toshiki Uchida, Hideki Tsujimura, Eiichi Ohtsuka, Nobuyuki Takayama, Kayoko Murayama, et al. Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study). BLOOD. 2022. 140. 11890-11892
-
Takashi Watanabe, Kensei Tobinai, Masashi Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, et al. Final Analysis of JCOG0203 for Advanced-Stage Indolent B-Cell Lymphoma 15 Years after the End of Enrollment: Pooled Analysis of Arms a and B for Follicular Lymphoma. BLOOD. 2022. 140. 3615-3617
-
後藤勇也, 中島崚亮, 榊原真由, 棚橋真規夫, 矢田啓二, 飯田浩充, 永井宏和, 岩越朱里, 西村理恵子, 山本涼子. A case of useful pleural effusion analysis by flow cytometry for accurate diagnosis of angioimmunoblastic T-cell lymphoma. 日本検査血液学会雑誌. 2022. 23. 2. 281-288
-
亀位 涼, 中嶋 琢人, 坂部 彩, 頭金 正博, 李 政樹, 飯田 真介, 丸山 大, 大佐賀 智, 福原 規子, 宮崎 香奈, et al. ボルテゾミブの有害事象に関わるバイオマーカー候補HLAアリルの探索. 臨床薬理. 2020. 51. Suppl. S301-S301
-
Ken Takase, Hirokazu Nagai, Moe Kadono, Takanori Yoshioka, Nobuyuki Yoshio, Yukio Hirabayashi, Takuo Ito, Morio Sawamura, Akihiro Yokoyama, Shinichiro Yoshida, et al. High-dose dexamethasone therapy as the initial treatment for idiopathic thrombocytopenic purpura. International journal of hematology. 2020. 111. 3. 388-395
ｍore...
Education (1)：
- - 現在 Kanazawa University school of medicine
Work history (1)：
- - 現在 National Hospital Organization Nagoya Medical Center Department of Hematology/Oncology Rearch Directror
Return to Previous Page
